Show simple item record

dc.contributor.authorVicente, Mariane C. [UNESP]
dc.contributor.authorAlmeida, Maria C.
dc.contributor.authorBícego, Kênia C. [UNESP]
dc.contributor.authorCarrettiero, Daniel C.
dc.contributor.authorGargaglioni, Luciane H. [UNESP]
dc.date.accessioned2019-10-06T15:58:09Z
dc.date.available2019-10-06T15:58:09Z
dc.date.issued2018-01-01
dc.identifierhttp://dx.doi.org/10.3233/JAD-180397
dc.identifier.citationJournal of Alzheimer's Disease, v. 65, n. 4, p. 1159-1174, 2018.
dc.identifier.issn1875-8908
dc.identifier.issn1387-2877
dc.identifier.urihttp://hdl.handle.net/11449/188128
dc.description.abstractBesides the typical cognitive decline, patients with Alzheimer's disease (AD) develop disorders of the respiratory system, such as sleep apnea, shortness of breath, and arrhythmias. These symptoms are aggravated with the progression of the disease. However, the cause and nature of these disturbances are not well understood. Here, we treated animals with intracerebroventricular streptozotocin (STZ, 2 mg/kg), a drug that has been described to cause Alzheimer-like behavioral and histopathological impairments. We measured ventilation (V E), electroencephalography, and electromyography during normocapnia, hypercapnia, and hypoxia in Wistar rats. In addition, we performed western blot analyses for phosphorylated tau, total tau, and amyloid-β (Aβ) peptide in the locus coeruleus (LC), retrotrapezoid nucleus, medullary raphe, pre-Bötzinger/Bötzinger complex, and hippocampus, and evaluated memory and learning acquisition using the Barnes maze. STZ treatment promoted memory and learning deficits and increased the percentage of total wakefulness during normocapnia and hypercapnia due to a reduction in the length of episodes of wakefulness. CO2-drive to breathe during wakefulness was increased by 26 in STZ-treated rats due to an enhanced tidal volume, but no changes in V E were observed in room air or hypoxic conditions. The STZ group also showed a 70 increase of Aβ in the LC and no change in tau protein phosphorylation. In addition, no alteration in body temperature was observed. Our findings suggest that AD animals present an increased sensitivity to CO2 during wakefulness, enhanced Aβ in the LC, and sleep disruption.en
dc.format.extent1159-1174
dc.language.isoeng
dc.relation.ispartofJournal of Alzheimer's Disease
dc.sourceScopus
dc.subjectBreathing
dc.subjectchemosensitivity
dc.subjectdementia
dc.subjecthypoxia
dc.subjectlocus coeruleus
dc.subjectstreptozotocin
dc.titleHypercapnic and Hypoxic Respiratory Response during Wakefulness and Sleep in a Streptozotocin Model of Alzheimer's Disease in Ratsen
dc.typeArtigo
dc.contributor.institutionUniversidade Estadual Paulista (UNESP)
dc.contributor.institutionUniversidade Federal do ABC (UFABC)
dc.description.affiliationDepartment of Animal Morphology and Physiology Sao Paulo State University-UNESP/FCAV at Jaboticabal Faculdade de Ciencias Agrariase Veterinarias, Via de acesso Paulo Donato Castellane s/n
dc.description.affiliationCenter for Natural and Human Sciences Universidade Federal Do ABC (UFABC)
dc.description.affiliationUnespDepartment of Animal Morphology and Physiology Sao Paulo State University-UNESP/FCAV at Jaboticabal Faculdade de Ciencias Agrariase Veterinarias, Via de acesso Paulo Donato Castellane s/n
dc.identifier.doi10.3233/JAD-180397
dc.rights.accessRightsAcesso aberto
dc.identifier.scopus2-s2.0-85054149988
Localize o texto completo

Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record